Investing £500 a month 5 years ago could have generated a passive income of…
It's never too late to start an investing journey in pursuit of passive income. But getting the ball rolling early on can make an enormous difference, even across just a few years. £500 a month is more than enough to build a significant second income stream in the long run. And for those that started from scratch five years ago, they're already have potentially generated £2,100 in their sleep.
Typically, investors seeking passive income will focus on dividend stocks. While that's a perfectly workable strategy, growth stocks are still a viable alternative choice. And when picked prudently, growth stocks can offer substantially better capital gains to build up a portfolio.
To demonstrate, let's take a look at the long-term performance of the FTSE 100 and FTSE 250. The former is by far more popular for its chunky dividends and relatively stable performance, driven by mature industry titans. As such, since its inception, investors have reaped annualised returns of roughly 8% a year. By comparison, the FTSE 250 has been a far more volatile beast, with small- and medium-sized businesses rising and falling. But among this seesaw behaviour, total returns have inched closer to 11% a year.
A 3% difference may not sound like much, but when compounded over decades, it makes an enormous difference.
£500 invested each month at these rates five years ago is now worth £36,738 and £39,759 respectively. But for those who started a further 10 years earlier, the gap grows exponentially to £173,020 and £227,345. And following the 4% withdrawal rule, that's a potential passive income of up to £9,094 without having to work a single extra day in the year.
Generating a near-11% annual return sounds easy on paper since there are plenty of FTSE 250 index trackers available.
Unfortunately, in recent years, the UK's growth index has underwhelmed. Even when measuring since the lows of the 2020 pandemic, index investors have only averaged 6.9% annualised gains.
Having said that, not all of its constituents have lagged behind. Games Workshop (LSE:GAW) has delivered explosive results with an average annualised gain of 21%! To put that into perspective, investing £500 a month for five years at this rate translates into a portfolio worth £52,340, or £2,100 passive income.
The Warhammer miniature manufacturer has continued to expand the audience for its IP with new miniature releases for its various tabletop games worldwide. And despite economic woes still plaguing economies worldwide, customers are still rushing to get the latest box sets and army kits. In fact, just a week ago, the group launched its pre-orders for new Warhammer 40,000 Chaos faction miniatures – some of which sold out in under five minutes.
With more miniature releases planned in 2025 and beyond, the growth engine still has plenty of fuel. There is the risk of tariff-related disruptions. After all, the company manufactures all of its products in the UK and then exports them to warehouses across the globe, including in the US, which is a core market.
Given the already premium price tag of these products, even a 10% added import tax could hurt American sales volumes. Nevertheless, with Warhammer becoming evermore popular, supported by a cult-like customer base, it's a business that investors might want to inspect more closely.
The post Investing £500 a month 5 years ago could have generated a passive income of… appeared first on The Motley Fool UK.
More reading
5 Stocks For Trying To Build Wealth After 50
One Top Growth Stock from the Motley Fool
Zaven Boyrazian has positions in Games Workshop Group Plc. The Motley Fool UK has recommended Games Workshop Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
Motley Fool UK 2025
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
Defence and gold in favour as FTSE 100 ekes out marginal gains
The FTSE 100 eked out marginal gains on Monday as advances in defence stocks helped offset nerves surrounding renewed US-China trade tensions. The FTSE 100 index closed up 1.88 points at 8,774.26. The FTSE 250 ended up just 0.96 of a point at 21,028.97, and the AIM All-Share closed up 1.45 points, 0.2%, at 748.13. Defence stocks climbed as Prime Minister Keir Starmer said the government will increase defence spending to 2.5% of gross domestic product from April 2027 with an ambition – but no firm commitment – to increase it to 3% during the next parliament. The Prime Minister said he was '100% confident' the plans in the new strategic defence review – including extra attack submarines, £15 billion on nuclear warheads and thousands of new long-range weapons – could be delivered on current funding plans. On the FTSE 100, Babcock International rose 8.3% while on the FTSE 250, Qinetiq advanced 4.5%. In European equities on Monday, the CAC 40 in Paris fell 0.2%, while the DAX 40 in Frankfurt eased 0.3%. European equities were held back by fresh developments in tariffs and renewed fears of a trade war between the US and China. Late on Friday, US President Donald Trump doubled tariffs on imported steel and aluminium to 50%, starting this Wednesday. At the same time, tensions with China resurfaced after Beijing rejected Mr Trump's accusations of violating the Geneva truce struck earlier in May. On Monday, China's commerce ministry said it had upheld the deal. It accused Washington of introducing 'a series of discriminatory and restrictive measures' in recent weeks that undermined the Geneva consensus and harmed 'China's legitimate rights and interests'. Hani Abuagla, senior market analyst at XTB MENA, said although US Treasury Secretary Scott Bessent suggested that a call between Mr Trump and China's President Xi Jinping may take place soon, markets remain wary of further escalation. 'The lack of clear progress risks reigniting trade volatility just as investors look for greater policy clarity,' Mr Abuagla added. The latest twist in the trade war saga saw renewed falls for the dollar and gains for the euro and sterling. The pound was quoted up at 1.3546 dollars late on Monday afternoon in London, compared with 1.3476 dollars at the equities close on Friday. The euro stood higher at 1.1429 dollars against 1.1348 dollars. Against the yen, the dollar was trading lower at 142.75 yen compared with 144.23 yen. The yield on the US 10-year Treasury widened to 4.46% from 4.41% on Friday. The yield on the US 30-year Treasury stretched to 5.00% from 4.92%. In New York, the Dow Jones Industrial Average was down 0.6% at the time of the London equities close on Monday. The S&P 500 was 0.3% lower and the Nasdaq Composite fell 0.1%. Investors weighed weaker-than-expected US manufacturing data. The seasonally adjusted S&P Global US manufacturing purchasing managers' index recorded 52.0 in May, rising from 50.2 in April. However, it fell short of the 52.3 flash estimate posted late last month. Meanwhile, figures from the Institute for Supply Management showed economic activity in the manufacturing sector contracted in May for the third consecutive month. The ISM manufacturing PMI registered 48.5 in May, compared with 48.7 in April, and below the 49.5 consensus. 'Manufacturing is muddling through tariff-related disruptions for the time being rather than falling apart, but the sector remains under intense pressure, with marked increases in the prices of many goods likely in the pipeline,' said Oliver Allen at Pantheon Macroeconomics. Data in Europe showed manufacturing was also subdued. The eurozone manufacturing sector remained in contraction in May but got closer to stabilisation, survey results from S&P Global showed on Monday. The Hamburg Commercial Bank manufacturing purchasing managers' index rose to 49.4 points in May from 49.0 in April, edging closer to the 50-point no-change mark. The final score was in line with the flash reading published late last month and reflects a 33-month-high. The PMI reading indicates a further easing of the manufacturing sector slowdown, S&P Global said, with the headline index reaching its highest level since August 2022. In the UK, the manufacturing sector also stayed in contraction territory in May, amid weak global demand and turbulent market conditions. The S&P Global UK manufacturing purchasing managers' index picked up to 46.4 points in May, from 45.4 in April, though it remained below the 50-point neutral mark. The reading topped the 45.1 point flash estimate. The renewed trade angst saw the price of safe haven gold shine once more. The yellow metal jumped to 3,371.47 dollars an ounce on Monday against 3,286.33 dollars. On AIM, Eagle Eye plummeted 43%. The London-based software-as-a-service marketing solutions company said Neptune Retail Solutions has, with effect from August 2, terminated a contract worth between £9 million and £10 million in annual revenue. It explained that the contract was to provide digital promotional services to a national US grocer, and that NRS in 2023 acquired digital promotions and content provider Quotient Technology Inc. 'The board is confident that this change has no impact on the group's growth opportunities, which remain strong,' Eagle Eye said. The biggest risers on the FTSE 100 were Babcock International up 77p at 1,013p, Endeavour Mining, up 154p at 2,406p, Fresnillo, up 70p at 1,233p, Rentokil Initial up 11.6p at 363.2p, and British Airways owner IAG, up 9.2p at 335.3p. The biggest fallers on the FTSE 100 were Ashtead Group down 177p at 4,158p, WPP, down 17.2p at 582.2p, Taylor Wimpey, down 2.6p at 116.9p, JD Sports Fashion, down 1.56p at 82.5p, and Spirax Group, down 105p at 5,610p. Brent oil was higher at 64.58 dollars a barrel at the time of the London equities close on Monday, compared with 62.53 dollars on Friday. Tuesday's UK corporate calendar has full-year results from utility Pennon Group and a trading statement from tobacco retailer British American Tobacco. The economic calendar on Tuesday has eurozone CPI and unemployment figures, and US factory orders data. Contributed by Alliance News Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 hours ago
- Yahoo
M&S: FTSE 100 share price growth helps swell CEO's pay before cyber attack
The rise in Marks & Spencer's (M&S) share price before the FTSE 100 giant was hit by a major cyber attack has helped its chief executive's pay swell to more than £7m, it has been revealed. Stuart Machin took home just over £7m for the retailer's latest financial year, up from the £5m he received for the prior 12 months. The rise in M&S's share price over the financial year to the end of March this year was a significant reason behind the boosted pay packet as the retailer's turnaround gained strength. Shares in M&S started its latest financial year priced at around 260p but ended the 12 months at around 356p – adding millions to the retailer's market capitalisation. According to its annual report, the company said almost £2.7m of the CEO's pay was attributable to the increase in the share price. However, M&S's share price suffered a dramatic decline after it revealed in April it was the subject of a major cyber attack, thought to be related to the hacking group Scattered Spider. It is expected that the attack will blow a £300m hole in its earnings this year and that online disruption will continue throughout June and into July. Its share price slumped from 411p to a low of 345p but has since started to recover. M&S said the cyber attack has prompted its remuneration committee to review the performance metrics and targets for the next performance share plan (PSP). It was reported last month that Machin could face a pay cut of more than £1m for M&S's current financial year because of the impact the cyber attack has had on the company's share price. In May, City AM reported that revenue at M&S had increased by six per cent to £13.8bn during its latest financial year. However, its pre-tax profit fell by almost 24 per cent to £511.8m over the same period. M&S also confirmed at the time that it would raise its annual dividend by 20 per cent to 3.6p per share this year. A M&S spokesperson said: 'CEO pay is decided by the board and reflects performance against stretching pre-set targets. 'Almost 90 per cent of Stuart's pay is linked to performance of the business and the share price – therefore his total pay for FY25 reflects the strong performance and growth of M&S under his leadership over the last three years. 'Over 75 per cent of Stuart's pay is made up of long-term and deferred share awards, subject to waiting periods and tied to future share price performance. 'This year, our strong performance meant we could make our biggest ever investment in store colleague pay. 'Additionally, over 5,000 colleagues, including store managers, received a bonus. We also returned more value to shareholders with an increased dividend payment.'
Yahoo
11 hours ago
- Yahoo
Drugmaker Indivior to abandon London listing amid exodus of companies
The drugmaker Indivior has become the latest company to abandon its listing in London, heaping further pressure on the London Stock Exchange (LSE) to reinvigorate itself. The Virginia-based company, which makes the opioid addiction treatments Sublocade and Suboxone, switched its main stock listing to the US last year, but now plans to cancel the secondary listing it had retained in London. Indivior said on Monday that in making the decision it had considered the liquidity and trading volumes of its shares on the US's Nasdaq exchange compared with the LSE; the location of its shareholders; and the cost and administrative requirements related to the London listing. More than 80% of Indivior's net revenues come from the US, which has been in the grip of an opioid crisis for decades, after a rise in the use of opioid painkillers led to increasing addiction rates and a sharp rise in fatal overdoses. David Wheadon, the Indivior chair, said: 'A single primary listing on Nasdaq best reflects the profile of Indivior's business. We appreciate the support received from shareholders for this initiative and look forward to capitalising on the expected benefits of this move, including reductions in cost and complexity.' The London-listed share price fell by 2% to 925.7p on Monday, giving Indivior a market value of nearly £1.2bn. The LSE has been hit by an exodus of companies, such as the Anglo-German travel company Tui, which opted for a sole listing in Frankfurt last year. 'The London Stock Exchange will be upset it is losing another big name,' said Russ Mould, the investment director at AJ Bell. 'It means the pressure is on to attract new names to the market and keep existing ones.' The blow was softened as the LSE welcomed Anglo American's $11bn (£8bn) platinum spin-off Valterra, which became independent from the mining company. Valterra is listed in South Africa and will now have a London listing as well. Anglo retains a 19.9% stake for now but has promised to sell it down over time. Mould said he had expected Indivior to exit London entirely, as its business is focused on the US, where most of its shareholders are based. The company had been listed in London because it was spun off in 2014 from the UK consumer goods group Reckitt Benckiser, itself listed in London. Indivior appointed the pharma veteran Joseph Ciaffoni as chief executive in February, replacing Mark Crossley after warning of a sharp drop in revenues this year. Last year it posted 9% sales growth to almost $1.2bn. This was driven by Sublocade, a prescription medicine that is injected once a month by health professionals to treat addiction to opioid drugs in adults, alongside mental health support. Suboxone is a similar drug but is given as tablets or as a film that dissolves when placed under the tongue. Sublocade's 2025 sales are expected to be flat compared with last year, while Suboxone film faces a 50% slump in sales because of competition from generic drugs, and Indivior will discontinue Perseris, its once-monthly schizophrenia drug. Indivior also said in February it faced 'numerous lawsuits', including an allegation that Suboxone film was 'defectively designed and caused dental injury'. There have also been cases brought by shareholders in the UK and US. Indivior faces a lawsuit from Wirral council, which administers the Merseyside Pension Fund, in London's high court over alleged false marketing of Suboxone. The case was thrown out in 2023; Wirral council appealed, and Indivior said in February it intended to 'vigorously defend' itself. In 2019, the US justice department charged Indivior with fraudulently claiming Suboxone film was better and safer than similar drugs. Its former parent, Reckitt, agreed to pay a $1.4bn fine to settle the case in July 2019, without any admission of wrongdoing, while Indivior said in 2020 that it had 'pleaded guilty to one count of making a false statement relating to healthcare matters in 2012' and that it would make payments to federal and state authorities totalling $600m over seven years. Shaun Thaxter, the former Indivior chief executive, was sentenced to six months in federal prison in 2020 after pleading guilty to his role in a scheme to secure Medicaid coverage for Suboxone film by misleading officials about its dangers to children.
